Primary mucosa-associated lymphoid tissue lymphoma of Waldeyer′s ring:clinical characteristics and long-term outcome
WU Run-ye, LI Ye-xiong, QI Shu-nan, LIU Qing-feng, JIN Jing, WANG Wei-Hu, SONG Yong-wen, WANG Shu-lian, LIU Yue-ping, REN Hua, FANG Hui, LU Ning-ning, ZHANG Xi-mei, CHEN Bo, LIU Xin-fan, YU Zi-hao
Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021,China Corresponding author:LI Ye-xiong, Email:yexiong3@yahoo.com.cn
Abstract：Objective To investigate the clinical characteristics and long-term outcome of patients with mucosa-associated lymphoid tissue (MALT) lymphoma of Waldeyer′s ring. Methods Ten patients were retrospectively analyzed. Seven patients had stage ⅠE and 3 patients had stage ⅡE disease. All patients received radiation therapy with a median dose of 40 Gy, and 7 patients also received 1 to 4 cycles of CHOP-based chemotherapy before radiation. Results The ratio of male to female was 1∶9. The median age was 58 years. No patient had B symptoms. One patient had elevated LDH level. The complete response rate after treatment was 100%. With median follow-up periods of 90 months, 1 patient died from rectal cancer. One patient developed brain metastasis and was salvaged by radiotherapy. The 5-year overall survival, cancer specific survival and progression-free survival rates were 90%, 100% and 80%, respectively. Conclusions The clinical characteristics of Waldeyer′s ring MALT lymphoma were similar to that of nongastric MALT lymphoma. For patients with Waldeyer′s ring MALT lymphoma, primary radiotherapy can result in excellent long-term survival.
[1] Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol,1999,36:139-147. [2] Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood,2000,95:802-806. [3] Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res,2005,11:3349-3352. [4] Raderer M, Whrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging:a single-center experience. J Clin Oncol,2006,24:3136-3141. [5] Arcaini L, Burcheri S, Rossi A, et al. Nongastric marginal-zone B-cell MALT lymphoma:prognostic value of disease dissemination. Oncologist,2006,11:285-291. [6] 李百周,陆洪芬,周晓燕,等. 不同部位黏膜相关淋巴组织结外边缘区B细胞淋巴瘤中染色体的异常及其意义.中华病理学杂志,2008,9:604-608. [7] Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood,2008,112:3057-3064. [8] Qi SN, Li YX, Wang H, et al. Diffuse large B-cell lymphoma:clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Cancer,2009,115:4980-4989. [9] Paulsen J, Lennert K. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type in Waldeyer′s ring. Histopathology,1994,24:1-11. [10] Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin′s lymphomas. J Clin Oncol,1999,17:1244-1253. [11] Zinzani PL, Magagnoli M, Galieni P,et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma:analysis of 75 patients. J Clin Oncol,1999,17:1254-1258. [12] El-Banhawy OA, El-Desoky I. Low-grade primary mucosa-associated lymphoid tissue lymphoma of the nasopharynx:clinicopathological study. Am J Rhinol,2005,19:411-416. [13] Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood,2003,101:2489-2495. [14] Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior:analysis of 108 patients. J Clin Oncol,1997,15:1624-1630. [15] Tanimoto K, Kaneko A, Suzuki S, et al. Primary ocular adnexal MALT lymphoma:a long-term follow-up study of 114 patients. Jpn J Clin Oncol,2007,37:337-344. [16] Oh SY, Ryoo BY, Kim WS, et al. Nongastric marginal zone B-cell lymphoma:analysis of 247 cases. Am J Hematol, 2007,82:446-452. [17] Bayraktar S, Bayraktar UD, Stefanovic A, et al. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT):single institution experience in a large cohort of patients. Br J Haematol,2011,152:72-80. [18] Suh C, Huh J, Roh JL. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region:a high rate of dissemination and disease recurrence. Oral Oncol,2008,44:949-955. [19] Tsai HK, Li S, Ng AK,et al. Role of radiation therapy in the treatment of stage Ⅰ/Ⅱ mucosa-associated lymphoid tissue lymphoma. Ann Oncol,2007,18:672-678. [20] 汪华,李晔雄,刘清峰,等.40例早期胃外黏膜相关淋巴组织淋巴瘤的治疗结果.中华放射肿瘤学杂志,2010,3:227-230. [21] Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer,2010,116:3815-3824. [22] Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma:a randomised phase Ⅲ trial. Radiother Oncol,2011,100:86-92.
2012, Vol. 21 
